Mineralys Therapeutics reports inducement award under Nasdaq Rule 5635(c)(4)
Mineralys Therapeutics (MLYS) reports an inducement award granted under Nasdaq Listing Rule 5635(c)(4), with no additional terms or magnitude provided in the feed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.